U.S. Radiotheranostics Market Size & Outlook, 2026-2033

Name: U.S. Radiotheranostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The radiotheranostics market in the United States is expected to reach a projected revenue of US$ 11,411.2 million by 2033. A compound annual growth rate of 8.6% is expected of the United States radiotheranostics market from 2026 to 2033.

Pharmaceuticals
- Radiotherapy/Nuclear Medicine
  - Radiotheranostics Market Outlook

U.S. radiotheranostics radioisotope outlook (Revenue, USD million, 2021-2033)
- Iodine-131
- Iodine-123
- Gallium-68
- Lutetium-177
- 18F with Y-90
- Others
U.S. radiotheranostics approach outlook (Revenue, USD million, 2021-2033)
- Targeted Therapeutic
- Targeted Diagnostic
U.S. radiotheranostics application outlook (Revenue, USD million, 2021-2033)
- Oncology
  - Thyroid Cancer
  - Neuroendocrine Tumor
  - Hepatocellular Carcinoma
  - Prostate Cancer
  - Others
- Non-Oncology
  - Neurological Disorders
  - Arthritis
  - Others

U.S. Radiotheranostics Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!